Your browser doesn't support javascript.
loading
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.
Andersen, Kathleen M; Bates, Benjamin A; Rashidi, Emaan S; Olex, Amy L; Mannon, Roslyn B; Patel, Rena C; Singh, Jasvinder; Sun, Jing; Auwaerter, Paul G; Ng, Derek K; Segal, Jodi B; Garibaldi, Brian T; Mehta, Hemalkumar B; Alexander, G Caleb.
Afiliação
  • Andersen KM; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Bates BA; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Rashidi ES; Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, USA.
  • Olex AL; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Mannon RB; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Patel RC; Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA.
  • Singh J; Division of Nephrology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Sun J; Department of Medicine and Department of Global Health, University of Washington, Seattle, WA, USA.
  • Auwaerter PG; Medicine Service, VA Medical Center, Birmingham, AL, USA.
  • Ng DK; Department of Medicine, School of Medicine and Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Segal JB; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Garibaldi BT; The Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Mehta HB; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Alexander GC; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Lancet Rheumatol ; 4(1): e33-e41, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34806036

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos